48,900 Shares in Senseonics Holdings, Inc. (NYSE:SENS) Acquired by Raymond James Financial Inc.

Raymond James Financial Inc. acquired a new stake in Senseonics Holdings, Inc. (NYSE:SENS) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 48,900 shares of the company’s stock, valued at approximately $26,000.

A number of other institutional investors have also recently bought and sold shares of SENS. HighTower Advisors LLC acquired a new stake in shares of Senseonics in the fourth quarter worth $32,000. Ridgecrest Wealth Partners LLC acquired a new position in Senseonics in the fourth quarter worth $60,000. Virtu Financial LLC acquired a new position in Senseonics in the fourth quarter valued at approximately $148,000. Renaissance Technologies LLC bought a new position in shares of Senseonics during the fourth quarter worth about $720,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in Senseonics by 9.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,339,698 shares of the company’s stock worth $1,748,000 after buying an additional 274,842 shares in the last quarter. 12.36% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

SENS has been the subject of a number of research reports. StockNews.com raised Senseonics to a “sell” rating in a research note on Monday. Mizuho initiated coverage on shares of Senseonics in a research report on Thursday, April 10th. They set an “outperform” rating and a $2.00 price objective on the stock. Finally, HC Wainwright reiterated a “buy” rating and issued a $2.00 target price on shares of Senseonics in a research note on Wednesday, March 5th.

Senseonics Stock Down 2.7%

Shares of SENS stock opened at $0.58 on Thursday. Senseonics Holdings, Inc. has a 12 month low of $0.25 and a 12 month high of $1.40. The stock has a 50 day moving average of $0.65 and a 200-day moving average of $0.63. The firm has a market cap of $379.05 million, a PE ratio of -4.46 and a beta of 1.05. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17.

Senseonics (NYSE:SENS) last announced its quarterly earnings results on Monday, March 3rd. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.09). Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. During the same quarter in the prior year, the business posted ($0.07) earnings per share. On average, equities analysts predict that Senseonics Holdings, Inc. will post -0.14 EPS for the current year.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.